AMR_Action_Fund

Fighting antibiotic resistance: Boehringer Ingelheim joins AMR Action FundCompany contributes USD 50 million to invest in antibiotic R&D within AMR Action FundAntimicrobial resistance (AMR) considered one of the most urgent global medical challengesJoint approach to combat the global threat of AMR 

Source: Boehringer Ingelheim Corporate News - July 9, 2020 Category: Research Source Type: news